Wolverine Trading’s Pacific Biosciences PACB Stock Holding History

Wolverine Trading’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$74K	Sell	59,213 -1,952	-3%	-$2.64K	﹤0.01%	5316
2025 Q2	$78.9K	Buy	61,165 +25,493	+71%	+$29.4K	﹤0.01%	4219
2025 Q1	$40.7K	Buy	35,672 +19,957	+127%	+$30.6K	﹤0.01%	4465
2024 Q4	$28.1K	Buy	15,715 +3,718	+31%	+$7.26K	﹤0.01%	5076
2024 Q3	$21K	Sell	11,997 -6,403	-35%	-$10.5K	﹤0.01%	4633
2024 Q2	$25.2K	Buy	18,400 +4,205	+30%	+$8.49K	﹤0.01%	4306
2024 Q1	$53.2K	Buy	+14,195	New	+$83.1K	﹤0.01%	4207
2018 Q4	–	Sell	-28,152	Closed	-$178K	–	5099
2018 Q3	$152K	Buy	+28,152	New	+$121K	﹤0.01%	4387
2017 Q3	–	Sell	-14,157	Closed	-$60.8K	–	4841
2017 Q2	$53K	Sell	14,157 -3,356	-19%	-$13.5K	﹤0.01%	4047
2017 Q1	$91K	Buy	+17,513	New	+$85.7K	﹤0.01%	3853
2016 Q4	–	Sell	-16,790	Closed	-$122K	–	4945
2016 Q3	$148K	Sell	16,790 -17,151	-51%	-$143K	﹤0.01%	4005
2016 Q2	$250K	Buy	+33,941	New	+$310K	﹤0.01%	3017

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Wolverine Trading's PACB Position: Q3 2025 in Review

Wolverine Trading reduced its Pacific Biosciences (PACB) stake by 3.2% in Q3 2025, selling an estimated $2.64K and leaving 59,213 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #5316.

Wolverine Trading first reported a position in PACB in Q2 2016 and has held it in 12 quarters since. The position peaked at $250K in Q2 2016. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

Wolverine Trading held 59,213 shares of Pacific Biosciences worth $74K as of Q3 2025.
Wolverine Trading sold 1,952 Pacific Biosciences shares in Q3 2025, an estimated $2.64K.
Pacific Biosciences made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5316 holding.
Wolverine Trading first reported a position in Pacific Biosciences in Q2 2016 and has held it in 12 quarters since.
Wolverine Trading's Pacific Biosciences position peaked at $250K in Q2 2016.
208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.